These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19358841)

  • 21. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts.
    Parikka V; Lehenkari P; Sassi ML; Halleen J; Risteli J; Härkönen P; Väänänen HK
    Endocrinology; 2001 Dec; 142(12):5371-8. PubMed ID: 11713237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice.
    Xiang A; Kanematsu M; Kumar S; Yamashita D; Kaise T; Kikkawa H; Asano S; Kinoshita M
    Bone; 2007 May; 40(5):1231-7. PubMed ID: 17347064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats.
    Kim MK; Kim HD; Park JH; Lim JI; Yang JS; Kwak WY; Sung SY; Kim HJ; Kim SH; Lee CH; Shim JY; Bae MH; Shin YA; Huh Y; Han TD; Chong W; Choi H; Ahn BN; Yang SO; Son MH
    J Pharmacol Exp Ther; 2006 Aug; 318(2):555-62. PubMed ID: 16699068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.
    Palmer JT; Bryant C; Wang DX; Davis DE; Setti EL; Rydzewski RM; Venkatraman S; Tian ZQ; Burrill LC; Mendonca RV; Springman E; McCarter J; Chung T; Cheung H; Janc JW; McGrath M; Somoza JR; Enriquez P; Yu ZW; Strickley RM; Liu L; Venuti MC; Percival MD; Falgueyret JP; Prasit P; Oballa R; Riendeau D; Young RN; Wesolowski G; Rodan SB; Johnson C; Kimmel DB; Rodan G
    J Med Chem; 2005 Dec; 48(24):7520-34. PubMed ID: 16302794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
    Xia L; Kilb J; Wex H; Li Z; Lipyansky A; Breuil V; Stein L; Palmer JT; Dempster DW; Brömme D
    Biol Chem; 1999 Jun; 380(6):679-87. PubMed ID: 10430032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
    Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
    Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
    Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity.
    Baugh M; Black D; Westwood P; Kinghorn E; McGregor K; Bruin J; Hamilton W; Dempster M; Claxton C; Cai J; Bennett J; Long C; McKinnon H; Vink P; den Hoed L; Gorecka M; Vora K; Grant E; Percival MD; Boots AM; van Lierop MJ
    J Autoimmun; 2011 May; 36(3-4):201-9. PubMed ID: 21439785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.
    Lin HS; Hu CY; Chan HY; Liew YY; Huang HP; Lepescheux L; Bastianelli E; Baron R; Rawadi G; Clément-Lacroix P
    Br J Pharmacol; 2007 Apr; 150(7):862-72. PubMed ID: 17325656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis.
    Rauner M; Thiele S; Sinningen K; Winzer M; Salbach-Hirsch J; Gloe I; Peschke K; Haegeman G; Tuckermann JP; Hofbauer LC
    Endocrinology; 2013 Oct; 154(10):3719-28. PubMed ID: 23885015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
    Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
    Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
    van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
    Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cathepsin K inhibitors as treatment of bone metastasis.
    Le Gall C; Bonnelye E; Clézardin P
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):218-22. PubMed ID: 18685424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates.
    Li Z; Hou WS; Brömme D
    Biochemistry; 2000 Jan; 39(3):529-36. PubMed ID: 10642177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T; Nishigaki F; Christgau S; Noto T; Mo J; From N; Minoura K; Hirayama Y; Ohkubo Y; Mutoh S
    J Rheumatol; 2004 Jun; 31(6):1174-9. PubMed ID: 15170932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis.
    Connor JR; LePage C; Swift BA; Yamashita D; Bendele AM; Maul D; Kumar S
    Osteoarthritis Cartilage; 2009 Sep; 17(9):1236-43. PubMed ID: 19361586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.